BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26278142)

  • 1. Outcomes of 167 healthy sibling donors after peripheral blood stem cell mobilization with G-CSF 16μg/kg/day: efficacy and safety.
    Krejci M; Janikova A; Folber F; Kral Z; Mayer J
    Neoplasma; 2015; 62(5):787-92. PubMed ID: 26278142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma.
    Demirer T; Buckner CD; Gooley T; Appelbaum FR; Rowley S; Chauncey T; Lilleby K; Storb R; Bensinger WI
    Bone Marrow Transplant; 1996 Jun; 17(6):937-41. PubMed ID: 8807097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of peripheral blood stem cell mobilization and collection: a single-center experience in 190 allogeneic donors.
    Rinaldi C; Savignano C; Pasca S; Sperotto A; Patriarca F; Isola M; Fanin R; De Angelis V
    Transfusion; 2012 Nov; 52(11):2387-94. PubMed ID: 22452363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes.
    Danylesko I; Sareli R; Bloom-Varda N; Yerushalmi R; Shem-Tov N; Shimoni A; Nagler A
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):277-283. PubMed ID: 26343949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Transplantation Group (GITMO).
    Majolino I; Cavallaro AM; Bacigalupo A; Rambaldi A; Falda M; Locatelli F; Raimondi R; Pucci G; Mordini N; Barbui T; Locatelli F; Rodeghiero F; Irrera G; Indovina A; Valbonesi M; Bellavita P; Tassi V; Perotti C; Soli M; Bresolin G
    Haematologica; 1997; 82(1):47-52. PubMed ID: 9107082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety comparison of mobilization and collection of hematopoietic stem cells between related and unrelated donors].
    Zhang S; Jin H; Xu LP; Liu DH; Chen H; Liang YQ; Li T; Li FX; Wang R; Kang Q; Chen YH; Zhang XH; Han W; Huang XJ; Liu KY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1017-22. PubMed ID: 20723320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield.
    Farhadfar N; Hsu JW; Logan BR; Sees JA; Chitphakdithai P; Sugrue MW; Abdel-Azim H; Anderlini PN; Bredeson C; Chhabra S; Diaz MA; Ganguly S; Hematti P; Kamble RT; Kasow KA; Lazarus HM; Lynch DK; Murthy HS; Olsson RF; Papari M; Przepiorka D; Savani BN; Schears R; Seo S; Solh MM; Spitzer T; Yared JA; Pulsipher MA; Shah NN; Switzer GE; Confer DL; Shaw BE; Wingard JR
    Blood Adv; 2020 Feb; 4(4):706-716. PubMed ID: 32092138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of hematocrit level for predicting the efficiency of peripheral blood CD34(+) cell collection after G-CSF Mobilization in Healthy Donors.
    Pornprasertsud N; Niparuck P; Kidkarn R; Puavilai T; Sirachainan N; Pakakasama S; Hongeng S; Jootar S; Ungkanont A
    J Clin Apher; 2015 Dec; 30(6):329-34. PubMed ID: 25663039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shorter donor leukocyte telomere length is associated with poor peripheral blood stem cell mobilization induced by granulocyte colony-stimulating factor.
    Yang SH; Liu HT; Wang TF; Liou YS; Sun DS; Wang JH; Chen LY
    J Formos Med Assoc; 2024 Jun; ():. PubMed ID: 38914514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies.
    Brown RA; Adkins D; Goodnough LT; Haug JS; Todd G; Wehde M; Hendricks D; Ehlenbeck C; Laub L; DiPersio J
    J Clin Oncol; 1997 Sep; 15(9):3067-74. PubMed ID: 9294469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
    Hohaus S; Martin H; Wassmann B; Egerer G; Haus U; Färber L; Burger KJ; Goldschmidt H; Hoelzer D; Haas R
    Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Successful Hematopoietic Stem Cell Collection in Healthy Allogeneic Donors.
    Kayser S; Schlenk RF; Steiner M; Klüter H; Wuchter P
    Transfus Med Hemother; 2023 Oct; 50(5):396-402. PubMed ID: 37899994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors affecting mobilization of peripheral blood stem/progenitor cells and apheresis efficiency from healthy donors by rhG-CSF].
    Liang ZY; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):847-51. PubMed ID: 18718074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting PBSC mobilization and collection in healthy donors.
    Lysák D; Koza V; Jindra P
    Transfus Apher Sci; 2005 Nov; 33(3):275-83. PubMed ID: 16209935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization.
    Rossi G; Skert C; Morello E; Almici C; Arcaini L; Basilico C; Cavalli L; Botto B; Castelli A; Pica G; Ripamonti F; Salvi F; Carella AM; Gaidano G; Levis A; Nosari A; Russo D; Vitolo U
    Hematol Oncol; 2015 Sep; 33(3):125-32. PubMed ID: 24890497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies.
    Kawamura K; Kikuchi M; Terasako K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Kimura S; Nakasone H; Okuda S; Yamazaki R; Kanda J; Kako S; Tanaka Y; Tanihara A; Nishida J; Kanda Y
    Transfus Apher Sci; 2013 Oct; 49(2):334-40. PubMed ID: 23810219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation.
    Shahzad M; Amin MK; Bellman P; Al-Ramahi J; Noor J; Vyas A; Mahmoudjafari Z; McGuirk M; DeJarnette S; Ahmed N; Abdallah AO; Shune L; Singh AK; McGuirk JP; Abhyankar S; Mushtaq MU
    Transfusion; 2024 Jun; ():. PubMed ID: 38847196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive parameters for granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.
    Okano A; Ashihara E; Shimazaki C; Uchiyama H; Inaba T; Taniguchi K; Maekawa T; Taniwaki M
    J Clin Apher; 2008; 23(6):171-7. PubMed ID: 18988229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.